PT  - JOURNAL ARTICLE
AU  - Gandhi, Deep B.
AU  - Khalili, Nastaran
AU  - Familiar, Ariana M.
AU  - Gottipati, Anurag
AU  - Khalili, Neda
AU  - Tu, Wenxin
AU  - Haldar, Shuvanjan
AU  - Anderson, Hannah
AU  - Viswanathan, Karthik
AU  - Storm, Phillip B.
AU  - Ware, Jeffrey B.
AU  - Resnick, Adam
AU  - Vossough, Arastoo
AU  - Nabavizadeh, Ali
AU  - Fathi Kazerooni, Anahita
TI  - Automated Pediatric Brain Tumor Imaging Assessment Tool from CBTN: Enhancing Suprasellar Region Inclusion and Managing Limited Data with Deep Learning
AID  - 10.1101/2024.07.29.24311006
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.07.29.24311006
4099  - http://medrxiv.org/content/early/2024/07/31/2024.07.29.24311006.short
4100  - http://medrxiv.org/content/early/2024/07/31/2024.07.29.24311006.full
AB  - Background Fully-automatic skull-stripping and tumor segmentation are crucial for monitoring pediatric brain tumors (PBT). Current methods, however, often lack generalizability, particularly for rare tumors in the sellar/suprasellar regions and when applied to real-world clinical data in limited data scenarios. To address these challenges, we propose AI-driven techniques for skull-stripping and tumor segmentation.Methods Multi-institutional, multi-parametric MRI scans from 527 pediatric patients (n=336 for skull-stripping, n=489 for tumor segmentation) with various PBT histologies were processed to train separate nnU-Net-based deep learning models for skull-stripping, whole tumor (WT), and enhancing tumor (ET) segmentation. These models utilized single (T2/FLAIR) or multiple (T1-Gd and T2/FLAIR) input imaging sequences. Performance was evaluated using Dice scores, sensitivity, and 95% Hausdorff distances. Statistical comparisons included paired or unpaired two-sample t-tests and Pearson’s correlation coefficient based on Dice scores from different models and PBT histologies.Results Dice scores for the skull-stripping models for whole brain and sellar/suprasellar region segmentation were 0.98±0.01 (median 0.98) for both multi- and single-parametric models, with significant Pearson’s correlation coefficient between single- and multi-parametric Dice scores (r > 0.80; p<0.05 for all). WT Dice scores for single-input tumor segmentation models were 0.84±0.17 (median=0.90) for T2 and 0.82±0.19 (median=0.89) for FLAIR inputs. ET Dice scores were 0.65±0.35 (median=0.79) for T1-Gd+FLAIR and 0.64±0.36 (median=0.79) for T1-Gd+T2 inputs.Conclusion Our skull-stripping models demonstrate excellent performance and include sellar/suprasellar regions, using single- or multi-parametric inputs. Additionally, our automated tumor segmentation models can reliably delineate whole lesions and enhancing tumor regions, adapting to MRI sessions with missing sequences in limited data context.Brief key points:Deep learning models for skull-stripping, including the sellar/suprasellar regions, demonstrate robustness across various pediatric brain tumor histologies.The automated brain tumor segmentation models perform reliably even in limited data scenarios.Importance of the Study We present robust skull-stripping models that work with single- and multi-parametric MR images and include the sellar-suprasellar regions in the extracted brain tissue. Since ∼10% of the pediatric brain tumors originate in the sellar/suprasellar region, including the deep-seated regions within the extracted brain tissue makes these models generalizable for a wider range of tumor histologies. We also present two tumor segmentation models, one for segmenting whole tumor using T2/FLAIR images, and another for segmenting enhancing tumor region using T1-Gd and T2/FLAIR images. These models demonstrate excellent performance with limited input. Both the skull-stripping and tumor segmentation models work with one- or two-input MRI sequences, making them useful in cases where multi-parametric images are not available – especially in real-world clinical scenarios. These models help to address the issue of missing data, making it possible to include subjects for longitudinal assessment and monitoring treatment response, which would have otherwise been excluded.Competing Interest StatementThe authors have declared no competing interest.Funding StatementResearch reported in this publication was supported by National Institute of Health Grant Fundings 75N91019D00024, Supplement 3U2CHL156291-03S2, Pediatric Brain Tumor Foundation and DIPG/DMG Research Funding Alliance (DDRFA)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study used openly available available pediatric brain MRI data from Children's Brain Tumor Network (CBTN) and BraTS-PEDs 2023 challenge.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors. All image processing tools that were used in this study are freely available for public use (CaPTk, https://www.cbica.upenn.edu/captk; ITK-SNAP, https://www.itksnap.org). The pediatric pre-processing and segmentation pipeline, along with pre-trained nnU-Net skull-stripping and tumor segmentation models are publicly available online at [https://github.com/d3b-center/peds-brain-seg-pipeline-public]. The stand-alone skull-stripping models are publicly available at [https://github.com/d3b-center/peds-brain-auto-skull-strip]. https://github.com/d3b-center/peds-brain-seg-pipeline-public https://github.com/d3b-center/peds-brain-auto-skull-strip